2015-02-11
Advances in the Management of Juvenile Idiopathic Arthritis
Publication
Publication
The coming of age of biologic treatment
Stappen vooruit in de behandeling van juveniele idiopathische artritis : het volgroeien van de behandeling met biologicals
Abstract
The main aim of this thesis was the evaluation of advances in the management of JIA. It focused on developments in the biologic treatment of JIA, using data from the ABC register. Additionally, it explored new biomarkers and methods for monitoring the disease activity, bone age and bone health of patients with JIA.
| Additional Metadata | |
|---|---|
| , | |
| A.J. van der Heijden (Bert) | |
| Erasmus University Rotterdam | |
| The ABC register was financially supported by the Dutch Board of Health Insurances (from 2003 to 2006), Pfizer (formerly Whyeth International, from 2007 to 2013) and AbbVie (formerly Abbott (from 2010 to 2012)). Printing of this thesis was financially supported by the Erasmus University Rotterdam, Dutch Arthritis Foundation (Reumafonds), Pfizer B.V., AbbVie B.V. and UCB Pharma B.V. | |
| hdl.handle.net/1765/77543 | |
| Organisation | Erasmus MC: University Medical Center Rotterdam |
|
Anink, J. (2015, February 11). Advances in the Management of Juvenile Idiopathic Arthritis. Retrieved from http://hdl.handle.net/1765/77543 |
|
